The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m(2)) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy

PURPOSE: When used in the second-line setting, single-agent chemotherapy has produced response rates of more than 10% or median survival times greater than 4 months. We studied the safety and efficacy of using second-line single docetaxel (75 mg/m(2)) for advanced NSCLC patients who were previously...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Shim, Byoung Yong, Kim, Chi Hong, Song, So Hyang, Ahn, Meyung Im, Hong, Eun Jung, Kim, Sung Whan, Kim, Suzy, Jo, Min Seop, Cho, Deog Gon, Cho, Kyu Do, Yoo, Jinyoung, Kim, Hoon-Kyo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2005
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785941/
https://ncbi.nlm.nih.gov/pubmed/19956369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2005.37.6.339
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi